title: Polypharmacy as part of comprehensive geriatric assessment: disclosure of false diagnosis of atrial fibrillation by drug revision.
authors.forename: Carmen
authors.initials: C
authors.lastname: Nogueras
authors.forename: Ramón
authors.initials: R
authors.lastname: Miralles
authors.forename: Alba
authors.initials: A
authors.lastname: Roig
authors.forename: Immaculada
authors.initials: I
authors.lastname: Llorach
authors.forename: Antoni M
authors.initials: AM
authors.lastname: Cervera
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D016477:Artifacts; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003951:Diagnostic Errors; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D015577:Geriatric Assessment / Q000379:methods*; D006801:Humans; D008508:Medication Errors; D019338:Polypharmacy; D014202:Tremor / Q000175:diagnosis*
chemical_list: D000889:Anti-Arrhythmia Agents; D005343:Fibrinolytic Agents; D000638:Amiodarone; D001241:Aspirin